This study provides the first mechanistic evidence that HBHA, an LTBI-associated antigen, inhibits macrophage autophagy via ECSIT targeting, offering critical insights into early immune evasion during latent infection and highlighting HBHA-ECSIT axis as a potential host-directed therapeutic target. This evidence concerns the gene ECSIT and disease arising from reactivation of latent virus.